首页> 美国卫生研究院文献>Oncoimmunology >Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer

【2h】

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer

机译：在抗HER2树突状细胞疫苗接种中添加抗雌激素疗法可改善ERpos / HER2pos早期乳腺癌患者的区域淋巴结免疫应答和病理完全应答率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Oncoimmunology
作者
Lea Lowenfeld; Salman Zaheer; Crystal Oechsle; Megan Fracol; Jashodeep Datta; Shuwen Xu; Elizabeth Fitzpatrick; Robert E. Roses; Carla S. Fisher; Elizabeth S. McDonald; Paul J. Zhang; Angela DeMichele; Rosemarie Mick; Gary K. Koski; Brian J. Czerniecki;
展开▼
作者单位

展开▼
年(卷),期 2017(6),9
年度 2017
页码 e1207032
总页数 12
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2(pos) early breast cancer [J] . Lowenfeld Lea, Zaheer Salman, Oechsle Crystal, Oncoimmunology. . 2017,第9期

机译：添加抗雌激素治疗对抗HERM2树突细胞疫苗接种可提高ERPOS / HER2（POS）早期乳腺癌患者的区域节点免疫应答和病理完全反应率
2. Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy [J] . Barron Alison U., Hoskin Tanya L., Day Courtney N., JAMA surgery . 2018,第12期

机译：ERBB2阳性或三阴性乳腺癌和乳房病理完全反应对Neoadjuvant化疗的患者患者低结节阳性率
3. Improved Natural Killer cell activity and retained anti-tumor CD8 + T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy [J] . E Muraro, E Comaro, R Talamini, Journal of Translational Medicine . 2015,第1期

机译：改善的自然杀伤细胞活性和保留的抗肿瘤CD8 + T细胞应答有助于在接受新辅助化疗的HER2阳性乳腺癌患者中诱发病理完全应答
4. Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Deep Learning with Integrative Imaging, Molecular and Demographic Data [C] . Hongyi Duanmu, Pauline Boning Huang, Srinidhi Brahmavar, International Conference on Medical Image Computing and Computer-Assisted Intervention . 2020

机译：利用综合成像，分子和人口统计数据预测对乳腺癌新辅助化疗的病理完全反应
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Pathological complete response to neoadjuvant chemotherapy but not the addition of carboplatin is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data [O] . Benjamín Walbaum, Francisco Acevedo, Lidia Medina, 2021

机译：对新辅助化疗的病理完全反应但不是加入卡铂与智利三重阴性乳腺癌患者的提高生存有关：现实世界数据的报告
7. Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy [O] . E Muraro, E Comaro, R Talamini, 2015

机译：改善的自然杀伤细胞活性和保留的抗肿瘤CD8 + T细胞应答有助于在接受新辅助化疗的HER2阳性乳腺癌患者中诱发病理完全应答

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ERpos/HER2pos early breast cancer

著录项

相似文献

相关主题

期刊订阅